Keryx Biopharmaceuticals Financial Market Data
| Last Close 18-Aug-2008 |
$0.39 |
Price/ Sales Ratio |
14.13 |
| 52-Week High |
$11.40 |
Price/ Book Ratio |
1.57 |
| 52-Week Low |
$0.35 |
Price/ Earnings Ratio |
-- |
| 60-Month Beta |
2.1 |
Price/ Cash Flow Ratio |
-- |
| Market Cap (mil.) |
$17.6 |
Return on Assets |
(116.7%) |
| Shares Outstanding (mil.) |
45.1 |
Return on Equity |
(177.3%) |
| Dividend Rate |
-- |
Current Ratio |
1.89 |
| Dividend Yield |
-- |
Long-Term Debt/Equity |
-- |
| # of Institutional Holders |
83 |
% Owned by Institutions |
48.0% |
| Latest Short Interest Ratio |
-- |
Latest Net Insider Transactions |
-- |
| Revenue Growth |
159.9% |
38.5% |
0.0% |
| EPS Growth |
0.0% |
0.0% |
0.0% |
| Dividend Growth |
0.0% |
0.0% |
0.0% |
This data is provided as per license from EDGAR Online
